Cancer Research Technology and the University of Manchester Announce Biomarker Alliance with AstraZeneca PLC
London, UK: 4th June 2007 - Cancer Research Technology Limited (CRT), the cancer-focused development and commercialisation company, and The University of Manchester today announce the establishment of an alliance with AstraZeneca to develop serological pharmacodynamic (PD) biomarkers.